published: Friday, March 1, 2019 at 08:15
Natalie Dreier, National Content Manager at Cox Media Group
– Another pharmaceutical company recalled its Losartan tablets because of the discovery of a trace of a potentially carcinogenic contaminant.
Camber Pharmaceuticals, Inc. recalled 87 batches of Losartan USP tablets. The recall concerns dosages of 25 mg, 50 mg and 100 mg. The recall was made because traces of N-methyl-4-amino-butyric acid (NMBA) were found in the drug. NMBA, which is a possible carcinogen to humans, is either a process impurity or a contaminant of an ingredient manufactured by a third party manufacturer, the Food and Drug Administration announced.
>> Read more new trends
The drug is used to treat high blood pressure or congestive heart failure. They come in 30, 90, 500 and 1000 pill bottles, according to the FDA.
The recalled medication has the following NDC numbers:
- Losartan 25 mg:
- Losartan 50 mg:
- Losartan 100 mg
For a complete list of lot numbers and expiry dates, click here.
Patients to whom the drug has been prescribed should contact their doctor.
For any questions regarding the recall, consumers may call Camber Pharmaceuticals' Medical Department at 1-866-495-1995, Monday through Friday, from 9:00 am to 5:00 pm IS.
The biggest product recall in the history of the United States